Immune evasion by murine melanoma mediated through CC chemokine receptor-10

被引:120
作者
Murakami, T
Cardones, AR
Finkelstein, SE
Restifo, NP
Klaunberg, BA
Nestle, FO
Castillo, SS
Dennis, PA
Hwang, ST
机构
[1] NCI, Dermatol Branch, NIH, Bethesda, MD 20892 USA
[2] NCI, Canc Therapeut Branch, CCR, NIH, Bethesda, MD 20892 USA
[3] NINDS, Bethesda, MD 20892 USA
[4] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland
关键词
metastasis; chemokine receptor; cancer; cell signaling;
D O I
10.1084/jem.20030593
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human melanoma cells frequently express CC chemokine receptor (CCR)10, a receptor whose ligand (CCL27) is constitutively produced by keratinocytes. Compared with B16 murine melanoma, cells rendered more immunogenic via overexpression of luciferase, B16 cells that overexpressed both luciferase and CCR10 resisted host immune responses and readily formed tumors. In vitro, exposure of tumor cells to CCL27 led to rapid activation of Akt, resistance to cell death induced by melanoma antigen-specific cytotoxic T cells, and phosphatidylinositol-3-kinase (PI3K)-dependent protection from apoptosis induced by Fas cross-linking. In vivo, cutaneous injection of neutralizing antibodies to endogenous CCL27 blocked growth of CCP10-expressing melanoma cells. We propose that CCR10 engagement by locally produced CCL27 allows melanoma cells to escape host immune antitumor killing mechanisms (possibly through activation of PI3K/Akt), thereby providing a means for tumor progression.
引用
收藏
页码:1337 / 1347
页数:11
相关论文
共 44 条
[1]   NONSPECIFIC AND SPECIFIC ACTIVE IMMUNOTHERAPY IN A B-16 MURINE MELANOMA SYSTEM [J].
AVENT, J ;
VERVAERT, C ;
SEIGLER, HF .
JOURNAL OF SURGICAL ONCOLOGY, 1979, 12 (01) :87-96
[2]   Chemokine biology in cancer [J].
Balkwill, F .
SEMINARS IN IMMUNOLOGY, 2003, 15 (01) :49-55
[3]   The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia [J].
Boehme, SA ;
Lio, FM ;
Maciejewski-Lenoir, D ;
Bacon, KB ;
Conlon, PJ .
JOURNAL OF IMMUNOLOGY, 2000, 165 (01) :397-403
[4]  
Böhm W, 1998, J IMMUNOL, V161, P897
[5]   Selective expression of FLIP in malignant melanocytic skin lesions [J].
Bullani, RR ;
Huard, B ;
Viard-Leveugle, I ;
Byers, HR ;
Irmler, M ;
Saurat, JH ;
Tschopp, J ;
French, LE .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) :360-364
[6]   Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer [J].
Bunn, PA ;
Franklin, W .
SEMINARS IN ONCOLOGY, 2002, 29 (05) :38-44
[7]  
Dreiling L, 1996, ADV INTERNAL MED, V41, P553
[8]   SELECTION OF SUCCESSIVE TUMOR LINES FOR METASTASIS [J].
FIDLER, IJ .
NATURE-NEW BIOLOGY, 1973, 242 (118) :148-149
[9]   Epidermal growth factor protects epithelial cells against Fas-induced apoptosis - Requirement for Akt activation [J].
Gibson, S ;
Tu, S ;
Oyer, R ;
Anderson, SM ;
Johnson, GL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (25) :17612-17618
[10]   The chemokine ESkine/CCL27 displays novel modes of intracrine and paracrine function [J].
Gortz, A ;
Nibbs, RJB ;
McLean, P ;
Jarmin, D ;
Lambie, W ;
Baird, JW ;
Graham, GJ .
JOURNAL OF IMMUNOLOGY, 2002, 169 (03) :1387-1394